- Home
- SOHO vs NRSN Comparison
SOHO vs NRSN Comparison
Compare SOHO & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- NRSN
- Stock Information
- Founded
- SOHO 2004
- NRSN 2017
- Country
- SOHO United States
- NRSN Israel
- Employees
- SOHO N/A
- NRSN N/A
- Industry
- SOHO Real Estate Investment Trusts
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- NRSN Health Care
- Exchange
- SOHO Nasdaq
- NRSN Nasdaq
- Market Cap
- SOHO 21.5M
- NRSN 17.8M
- IPO Year
- SOHO 2004
- NRSN 2021
- Fundamental
- Price
- SOHO $0.86
- NRSN $1.09
- Analyst Decision
- SOHO Hold
- NRSN Hold
- Analyst Count
- SOHO 1
- NRSN 1
- Target Price
- SOHO $1.50
- NRSN N/A
- AVG Volume (30 Days)
- SOHO 49.3K
- NRSN 294.5K
- Earning Date
- SOHO 03-05-2025
- NRSN 12-18-2024
- Dividend Yield
- SOHO N/A
- NRSN N/A
- EPS Growth
- SOHO N/A
- NRSN N/A
- EPS
- SOHO N/A
- NRSN N/A
- Revenue
- SOHO $179,860,606.00
- NRSN N/A
- Revenue This Year
- SOHO N/A
- NRSN N/A
- Revenue Next Year
- SOHO $0.70
- NRSN N/A
- P/E Ratio
- SOHO N/A
- NRSN N/A
- Revenue Growth
- SOHO 3.98
- NRSN N/A
- 52 Week Low
- SOHO $0.81
- NRSN $0.51
- 52 Week High
- SOHO $1.54
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- SOHO 37.81
- NRSN 47.45
- Support Level
- SOHO $0.81
- NRSN $1.01
- Resistance Level
- SOHO $0.93
- NRSN $1.13
- Average True Range (ATR)
- SOHO 0.06
- NRSN 0.09
- MACD
- SOHO -0.00
- NRSN -0.01
- Stochastic Oscillator
- SOHO 28.37
- NRSN 31.03
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.